Legitimacy of Entry-Oriented Strategy in DeBakey I Dissection in the Era of Endovascular Therapy
Background: Legitimacy of entry-oriented therapy for DeBakey I aortic dissection is of eminent importance in the era of emerging ascending aorta endovascular therapy. This study aims to evaluate early, midterm, and reintervention results of entry-oriented operative strategy compared to more aggressive strategies for treatment of DeBakey type I aortic dissection with an isolated intimal tear in the ascending aorta.
Methods: This study prospectively followed 98 consecutive patients who received an operation for DeBakey type I aortic dissection with the intimal tear in the ascending aorta between 2007 and 2013 for up to 6 years. Follow-up included survival, medical therapy, CT-imaging results, and reinterventions. Patients were grouped into entry-oriented (group I) receiving an isolated replacement of the ascending aorta and/or hemiarch (65 patients); and aggressive therapy (group II) receiving a replacement of the ascending aorta and complete aortic arch (33 patients).
Results: The in-hospital mortality was 19% and 23% respectively. The 3-year survival was 52% and 47% respectively (P = .193). Group II showed no advantage regarding persistence or progression of the dissection, thrombosis of false lumen, increase in aortic diameter, peripheral organ malperfusion (as assessed by follow-up computed tomography imaging) or freedom from reintervention.
Conclusion: In treating DeBakey I aortic dissection with an entry tear in the ascending aorta, it might be legitimate to adopt an entry-oriented operative strategy. Further research is also needed to clearly describe the indication of extending the operative strategy in such cases.
Conzelmann LO, Kruger T, Hoffmann I, et al. 2011. German Registry for Acute Aortic Dissection Type A (GERAADA): initial results. Herz 36:513-24.
Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. 1970. Management of acute aortic dissections. Ann Thorac Surg 10:237-47.
Debakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. 1965. Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg 49:130-49.
Di Eusanio M, Berretta P, Cefarelli M, et al. 2015. Total Arch Replacement Versus More Conservative Management in Type A Acute Aortic Dissection. Ann Thorac Surg 100:88-94.
Easo J, Weigang E, Holzl PP, et al. 2012. Influence of operative strategy for the aortic arch in DeBakey type I aortic dissection: analysis of the German Registry for Acute Aortic Dissection Type A. J Thorac Cardiovasc Surg 144:617-23.
Hagan PG, Nienaber CA, Isselbacher EM, et al. 2000. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 283:897-903.
Haldenwang PL, Wahlers T, Himmels A, et al. 2012. Evaluation of risk factors for transient neurological dysfunction and adverse outcome after repair of acute type A aortic dissection in 122 consecutive patients. Eur J Cardiothorac Surg 42:e115-20.
Hata M, Akiyama K, Hata H, et al. 2013. Early and midterm outcomes of quick proximal arch replacement with mild hypothermia and rapid rewarming for type A acute aortic dissection. J Thorac Cardiovasc Surg 146:119-23.
Isselbacher EM. 2007. Epidemiology of thoracic aortic aneurysms, aortic dissection, intramural hematoma, and penetrating athersclerotic ulcers. In: Eagle KA, Baliga RR, Isselbacher EM, Nienaber CA, eds. Aortic dissection and related syndromes. New York: Springer Science+Business Media. pp. 3-16.
Legras A, Bruzzi M, Nakashima K, Hillion ML, Loisance D, Kirsch M. 2012. Risk factors for hospital death after surgery for type A aortic dissection. Asian Cardiovasc Thorac Ann 20:269-79.
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13.
Nienaber CA, Fattori R, Mehta RH, et al. 2004. Gender-related differences in acute aortic dissection. Circulation 109:3014-21.
Nienaber C, Sakalihasan N, Clough R, et al. 2017. Thoracic endovascular aortic repair (TEVAR) in proximal (Type A) aortic dissection: ready for a broader application? JCTVS 153:S3-S11.
Omura A, Miyahara S, Yamanaka K, et al. 2016. Early and late outcomes of repaired acute DeBakey type I aortic dissection after graft replacement. J Thorac Cardiovasc Surg 151:341-8.
Rice RD, Sandhu HK, Leake SS, et al. 2015. Is total arch replacement associated with worse outcomes during repair of acute type A aortic dissection? Ann Thorac Surg 100:2159-65.
Truls M, Santi T, Vincenzo R. 2007. Cardiovascular surgery in the initial treatment of aortic dissection and acute aortic syndromes. In: Eagle KA, Baliga RR, Isselbacher EM, Ninaber CA, eds. Aortic dissection and related syndromes. New York: Springer Science+Business Media. pp. 167-90.
Tsai TT, Trimarchi S, Nienaber CA. 2009. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg 37:149-59.
Uchida N, Shibamura H, Katayama A, Shimada N, Sutoh M. 2009. Total arch replacement with an open stent graft for acute type A aortic dissection: fate of the false lumen. Eur J Cardiothorac Surg 35:83-8.
Uchida N, Katayama A, Tamura K, Sutoh M, Kuraoka M, Ishihara H. 2011. Frozen elephant trunk technique and partial remodeling for acute type A aortic dissection. Eur J Cardiothorac Surg 40:1066-71.
Uchida N, Katayama K, Takahashi S, Sueda T. 2013. Endovascular stent grafting of the downstream aorta after complete arch replacement using the frozen elephant trunk technique for acute type A aortic dissection. Eur J Cardiothorac Surg 43:196.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).